Sai Life Sciences Limited IPO
MainboardPharmaceuticals
Listed On: Dec 18, 2024 at ₹ 650.0(NSE)
₹ 14823 /27 Shares
Check AllotmentPrice Summary
Last Closing
745.75 (35.84%)52 Week High
808.8052 Week Low
650.00Last Update
30-Dec-2024 3:30 PM11 Dec, 2024
Open Date13 Dec, 2024
Close Date16 Dec, 2024
Allotment Date18 Dec, 2024
Listing DateIssue Price
₹522-549 per equity shareFace Value
₹1 Per Equity ShareListing at Group
BSE, NSERegistrar
Kfin Technologies LimitedList Price
650.0(NSE)Listing Date
2024-12-18Market Lot
Retail : 27 Shares (₹14,823/-)S-HNI : 378 Shares (₹2,07,522/-)
B-HNI : 1,836 Shares (₹10,07,964/-)
Lead Manager
Kotak Mahindra Capital Company LimitedJefferies India Private Limited
Morgan Stanley India Company Pvt Ltd
Iifl Securities Ltd
Issue Size
Total ₹3,042.62 Cr :#Fresh Issue : 17,304,189 shares(aggregating up to ₹950 Cr) +
#OFS : 38,116,934 shares of ₹1(aggregating up to ₹2,092.62 Cr)
Retail Portion
35% (Number of Retail Applications: 7,18,422 Approx),(Number of S-HNI Applications : 7,331 Approx),
(Number of B-HNI Applications : 14,662 Approx)
Subscription
10.26 timesSai Life Sciences IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 11,084,225 | 8,313,168 5,542,113 2,771,056 | 19,397,392 | 38,794,785 |
| Day 1 - 11-12-24 05:00 PM | 2.62 x | 0.15 0.15 x 0.17 x | 0.18 x | 0.84 x |
| Day 2 - 12-12-24 05:00 PM | 3.32 x | 0.59 0.58 x 0.62 x | 0.42 x | 1.25 x |
| Day 3 - 13-12-24 05:00 PM | 30.93 x | 4.92 6.00 x 2.74 x | 1.37 x | 10.26 x |
Sai Life Sciences Valuations
EPS Pre IPO
4.34EPS Post IPO
2.69P/E Pre IPO
126.42P/E Post IPO
203.82RoNW
8.13%Sai Life Sciences Company Financials All values are in ₹ Cr.
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 2,275.14 | 2,186.65 | 2,164.23 |
| Revenue | 1,494.27 | 1,245.11 | 897.74 |
| Profit After Tax | 82.81 | 9.99 | 6.23 |
About The Company
Headquartered in January 1999, Sai Life Sciences Limited is a leading pharmaceutical firm specializing in the research and development and manufacturing of small-molecule new chemical entities (NCEs). It collaborates with global biotech firms and pharmaceutical giants and delivers customized solutions across the drug discovery and development continuum.
In FY 2024, Sai Life Sciences serviced over 280 pharmaceutical innovators, including 18 of the top 25 global pharmaceutical companies by revenue (2023). The company supported more than 230 clients in its key markets, such as the US, UK, Europe, and Japan alone in September 2024.
Sai Life Sciences is different for being an integrated CRDMO, offering end-to-end solutions fully combining discovery, development, and manufacturing. Its CRO services give a solid stage for discovery, and in its CDMO, all scaling is done reliably to take on commercial and developmental work.
Sai Life Sciences - Strength and Weakness
Sai Life Sciences is one of India's largest CRDMOs by revenue.
Diverse product portfolio with 38 products and 7 blockbuster drugs.
Strong R&D infrastructure, offering integrated services and global talent.
Fastest-growing CRDMO with improving profitability and revenue growth metrics.
Dependent on biotechnology and pharmaceutical customers, facing industry-specific risks.
Manufacturing delays or interruptions could lead to higher costs and risks.
Heavy reliance on international revenue, facing risks of operational delays.
Sai Life Sciences - Peers Comparison
| P/B Ratio | P/E Ratio | RoNW | Net Worth | |
|---|---|---|---|---|
| Sai Life | 9.82 | 92.3 | 8.50% | 9,763 |
| Divis Lab | 11.9 | 88.6 | 12.2% | 8.614 |
| Suven Pharma | 16.8 | 137 | 24.1% | 961 |
| Syngene International | 8.42 | 80.3 | 13.2% | 3,451 |
Sai Life Sciences - Promoter(s)
Pre Issue Share Holding: 40.48%
Post Issue Share Holding: N/A%
- Kanumuri Ranga Raju
- Krishnam Raju Kanumuri
- Kanumuri Mytrey
- Sai Quest Syn Private Limited
- Sunflower Partners
- Lily Partners
- Marigold Partners
- Tulip Partners
Sai Life Sciences IPO - Issue Objectives
- Repayment/prepayment in full or part, of all or certain outstanding borrowings availed by the Company
- General corporate purposes
Sai Life Sciences IPO - Anchor Investors
Several marquee names in the anchor book including INQ Holdings, Smallcap World Fund, Fidelity, Blackrock, Abu Dhabi Investment Authority, Goldman Sachs, TIMF Holdings, Morgan Stanley, and Eastspring Investments.
HDFC Mutual Fund, Nippon Life India, Axis Mutual Fund, Kotak Mahindra AMC, Aditya Birla Sun Life AMC, DSP MF, Mirae Asset, SBI Life Insurance, UTI Mutual Fund, Whiteoak Capital, Bandhan Mutual Fund, Franklin, HSBC MF, Invesco, Max Life Insurance, Aditya Birla Sun Life Insurance, and Kotak Mahindra Life Insurance among domestic institutional investors also invested in the company.
Other Details
Sai Life Sciences
Plot No. DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: sailifesciences.ipo@kfintech.com
Sai Life Sciences IPO - FAQs
Ans. Sai Life Sciences Limited IPO is a Mainboard IPO. The issue is priced at ₹522-549 per equity share. The minimum order quantity is 27 Shares. The IPO opens on Dec 11, 2024, and closes on Dec 13, 2024. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Sai Life Sciences Limited IPO opens on Dec 11, 2024 and closes on Dec 13, 2024.
Ans. The size of Sai Life Sciences Limited IPO is Total ₹3,042.62 Cr : #Fresh Issue : 17,304,189 shares(aggregating up to ₹950 Cr) + #OFS : 38,116,934 shares of ₹1(aggregating up to ₹2,092.62 Cr).
Ans. The IPO price band is set between ₹522-549 per equity share.
Ans. To apply for Sai Life Sciences Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Sai Life Sciences Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Sai Life Sciences Limited IPO is Dec 16, 2024.
Ans. The Sai Life Sciences Limited IPO will be listed on Dec 18, 2024.
Ans. Follow the steps to check the allotment status for Sai Life Sciences Limited IPO here.
